Figma Inc. (FIG)

The panel's take

Verdict: HOLD · Conviction: MEDIUM · Last price: USD 23.65 (July 14, 2026)

Figma is caught at an inflection point where the fundamental case is real — 139% NRR, 46% growth, $1.58B net cash, fortress balance sheet — but priced as if the market has already resolved its central uncertainty (whether AI expands or disrupts the design workflow). The panel splits 3 bullish, 2 neutral, 1 bearish. The bulls argue AI expands the addressable surface; the bears argue it disintermediates Figma's moat by making Claude Design a direct retail threat. The consensus is quality at contested valuation — fair price, not a margin-of-safety price, in a macro and competitive headwind environment.

---

Key levels

Resistance: The $31.80 level (200-day MA) is the first structural ceiling; a break and hold would signal a shift from sideways consolidation to a new uptrend. Current price sits under the 50-day and 100-day moving averages, reflecting a lack of momentum — the stock is waiting for either a catalyst (Q3 guidance, Claude Design resilience proof) or a pullback confirmation (test of S2 at $19.50).

Current price: At $23.65, Figma sits in a mid-zone with limited margin of safety — the bull case (AI expands TAM, NRR holds 135%+) is roughly priced in, but the bear case (Claude Design is a moat crack, SBC dilution overstated) is not. Consensus analyst target is ~$30.56 (limited upside), and the panel's fair-value estimates range from $15–17 (bear) to $35–40 (bull).

Support: The 200-day MA at $21.80 is uptrend support; loss would signal a deeper pullback. The $19.50 zone is where value investors see accumulation potential (SBC concerns baked in). Through-cycle fair value sits deeper, near $15–17, if Claude Design proves to be structural headwind rather than temporary competitive noise.

---

What legendary investors think

We ran Figma past a panel of six legendary investors' frameworks.

---

Where they agree — and where they clash

Common ground:

• Quality metrics are genuine — 82% gross margin, 139% NRR, 46% YoY growth, $1.58B net cash, 690K paid customers (+54% YoY) are real quality signals. This is not a broken business.
• The IPO peak at $142.92 was froth — 83% drawdown has eliminated speculative excess.
• AI is the central uncertainty — whether Claude Design/competitors expand or disintermediate the design workflow will shape the next decade of value creation or destruction.
• SBC dilution is material — at 51% of Q1 revenue ($169M SBC on $333M revenue), stock-based compensation is the single largest gap between bull-case consensus price targets and intrinsic valuation when expensed properly.

The real debates:

Debate #1: Does AI Expand or Disintermediate Figma's Moat?

• The Disruption Platform & The Contrarian argue AI expands the addressable surface — non-designers now "make" in Figma via AI-assisted features (Make, Weave). Figma Make WAU +70%, paid customers +54%. TAM grows when new personas buy. NRR sustained at 139% proves the value unit is expanding, not fragmenting.
• The Valuation Engineer & The Moat Compounder counter: Anthropic sells Claude Design directly at retail. Figma buys Claude tokens wholesale and marks them up. That's a retailer-to-wholesaler conversion — margin compression embedded in unit economics. CEO selling 174k shares 3 days before Claude Design's launch reads as loss of conviction. The market hasn't priced this structural risk.

Debate #2: Is the Current Price Bullish or Neutral Valuation?

• The GARP Operator sees PEG 0.23–0.87 as screaming buy. Rule of 40 = 62–73 (best-in-class trajectory). Growth is re-accelerating; the market is still cautious. Fair value is higher.
• The Valuation Engineer responds: Rule of 40 ignores dilution. When SBC is expensed properly (8–13% terminal, not 51% current), fair value drops to ~$15–17. Current $23.65 embeds the bull-case outcome — limited upside for a story with unresolved, actively deteriorating central uncertainty.

Debate #3: Growth Deceleration or Reacceleration?

• The Disruption Platform & GARP Operator highlight Q1 FY26 reacceleration (40% → 46% YoY) and raised FY26 guidance (~35%). AI is driving new-persona adoption. Inflection is underway.
• The Macro Navigator counters: Fed likely holds/hikes (74.9% probability); tech-SaaS sentiment is fragile. Weekly chart shows Death Cross intact. $31.63 (200-day MA) is a 34% overhead hurdle in a macro headwind environment. Earnings aren't the blocker; macro is.

---

The numbers

Metric	Q1 2026	FY2025	Assessment
Revenue	$333.4M (+46% YoY)	~$1.27B	Reaccelerating from 40%; guidance raised to ~35% for FY26
Paid Customers	690K (+54% YoY)	~632K	Logo growth intact; land-and-expand narrative supported
NRR	139%	133%	Best-in-class; trending up, not down. Anchors bull case.
Gross Margin (non-GAAP)	82%	~80%	Structurally strong; SBC is the margin mirage.
Operating Margin (non-GAAP)	16%	~(2%) GAAP	SBC now ~$169M/quarter = 51% of revenue. Expensed GAAP margin closer to 2–3%.
SBC as % of Revenue	~51%	~40% (normalized)	IPO-cliff inflated; consensus assumes 8–13% terminal. KEY VALUATION DRIVER.
Net Cash	$1.58B	$1.64B	Strong balance sheet; no leverage. All-equity story.
Short Interest	42.4% of float	Elevated	Market skeptics present; capitulation squeeze possible or breakdown risk.
P/E (TTM)	~179x	-	Extreme; inflated by post-IPO accounting. Fair value depends entirely on SBC treatment.
Analyst Consensus Target	~$30.56	-	Only +29% upside despite the growth; targets revised but still below $31.63 (resistance).

Figures from Figma Q1 2026 (quarter ended March 31, reported May 7, 2026) / current pricing July 14, 2026; sourced from Figma IR, Investing.com, stockanalysis.com. Through-cycle fair values per investor models: The Valuation Engineer ~$15–17, The Contrarian & Disruption Platform ~$35–40+, The Moat Compounder ~$20–25 (awaiting thesis clarity).

---

The bottom line

Figma at $23.65 is a HOLD — a quality growth story at contested valuation.

Figma is the panel's clearest "the fundamentals are real, but the price reflects bullish assumptions that remain unproven" call. The bull case is compelling: 139% NRR, 46% growth, $1.58B net cash, fortress capital, and AI-driven new-persona adoption (Figma Make WAU +70% q/q, paid customers +54%) paint a picture of a durable, expanding business. The 83% drawdown from IPO peak has cleared froth, and the market's 42.4% short interest suggests despair pricing where quality should trade at a premium. But the panel's caution is equally concrete and, at this price, decisive: the stock trades at ~179x trailing earnings and ~63x forward earnings (extreme even for a 46%-growth SaaS), with every fair-value estimate on the panel ($15–17 bear, $25–35 base, $40+ bull) dependent on a single unresolved assumption: whether Claude Design is a durable threat (bear case) or a temporary competitive noise (bull case) that the NRR holds through. Tellingly, even the two bulls (Disruption, GARP) explicitly want proof, not conviction today — they want to see Q3 NRR resilience or a pullback before adding. What would tip the call bullish: a Q3 earnings print showing NRR holding above 135% after Claude Design's July launch, plus management's explicit repricing of the AI opportunity. What keeps it a HOLD is that absence of that confirmation, buyers are paying for flawless execution in an increasingly crowded AI design layer — where Anthropic's retail distribution and cost structure give them margin advantages Figma can't overcome if the workflow truly disintermediates. The magnitude of the quality metrics (82% gross margin, 46% growth, 139% NRR) and the panel's genuine disagreement (3 bullish, 2 neutral, 1 bearish, all medium conviction) is why this is HOLD, not SELL — but it's also why this is HOLD, not BUY, without either proof of AI resilience or a pullback to $19–21 where SBC concerns are better reflected.

This is analysis, not investment advice. Consult a qualified financial advisor before making any investment decisions.

---

Catalyst calendar: July 14 Claude Design launch (passed) · August–September Q2 earnings + guidance (critical NRR read post-Claude) · Q3 earnings (Oct/Nov, thesis validation window)

Next review trigger: Q2/Q3 earnings confirmation, Claude Design adoption data, or technical break of $31.80 resistance